Stock Code: 002772 stock abbreviation: Tianshui Zhongxing Bio-Technology Co.Ltd(002772) Announcement No.: 2022-003 bond Code: 128026 bond abbreviation: Zhongxing convertible bond
Tianshui Zhongxing Bio-Technology Co.Ltd(002772)
Announcement on resolutions of the 10th meeting of the 4th board of directors
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Convening of board meeting
The 10th meeting of the 4th board of directors of Tianshui Zhongxing Bio-Technology Co.Ltd(002772) (hereinafter referred to as “the company”) was held by means of communication in the company conference room of Tianshui national agricultural science and Technology Park on January 12, 2022. The meeting was presided over by Mr. Gao boshu, chairman of the company. The notice of the meeting was sent to all directors and senior managers by e-mail on January 9, 2022. There were 9 directors who should attend the meeting, and 9 directors actually attended the meeting. The company’s supervisors, senior managers and the Secretary of the board of directors attended the meeting as nonvoting delegates.
The meeting was convened and held in accordance with the company law and other laws and regulations and the articles of association.
2、 Deliberations of the board meeting
After careful consideration by the directors present, the following proposals were adopted by open ballot at this meeting: (I) the proposal on by election of independent director candidates of the Fourth Board of directors was considered and adopted
After the qualification examination of the nomination committee of the board of directors, the board of directors of the company plans to nominate Ms. Dang Lin as the candidate for independent director of the Fourth Board of directors of the company, with a term of office from the date of deliberation and approval by the general meeting of shareholders to the date of expiration of the term of office of the Fourth Board of directors.
The independent directors of the company expressed their independent opinions.
Voting: 9 in favor, 0 against, 0 abstention and 0 withdrawal
Voting result: adopted
This proposal needs to be submitted to the first extraordinary general meeting of shareholders of the company in 2022 for deliberation.
The announcement on by election of independent directors (Announcement No.: 2022-004) is detailed in the information disclosure media designated by the company, securities times, China Securities News and cninfo.com（ http://www.cn.info.com.cn. ）。
(II) the proposal on convening the company’s first extraordinary general meeting in 2022 was reviewed and approved. The board of directors of the company proposed to convene the first extraordinary general meeting in 2022 at 2:30 p.m. on Friday, January 28, 2022 in the company’s conference room to review the proposals considered and adopted at the 10th meeting of the Fourth Board of directors that need to be submitted to the general meeting for deliberation.
Voting: 9 in favor, 0 against, 0 abstention and 0 withdrawal
Voting result: adopted
The notice on convening the first extraordinary general meeting of shareholders in 2022 (Announcement No.: 2022-007) is detailed in the information disclosure media designated by the company on January 13, 2022, such as securities times, China Securities Journal and cninfo.com（ http://www.cn.info.com.cn. ）。
3、 Documents for future reference
Resolution of the Tianshui Zhongxing Bio-Technology Co.Ltd(002772) 10th meeting of the 4th board of directors
It is hereby announced
Tianshui Zhongxing Bio-Technology Co.Ltd(002772) board of directors January 12, 2022
